Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,606 | -6,010 |
| Depreciation Amortization | 27 | 90 |
| Other Working Capital | 197 | 180 |
| Other Operating Activity | 56 | 280 |
| Operating Cash Flow | $-2,326 | $-5,460 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -20 | -190 |
| Investing Cash Flow | $-20 | $-190 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -12 | N/A |
| Common Stock Issued | 63 | N/A |
| Other Financing Activity | 0 | -50 |
| Financing Cash Flow | $51 | $-50 |
| Beginning Cash Position | 12,152 | 17,860 |
| End Cash Position | 9,857 | 12,150 |
| Net Cash Flow | $-2,295 | $-5,710 |
| Free Cash Flow | ||
| Operating Cash Flow | -2,326 | -5,460 |
| Capital Expenditure | -20 | N/A |
| Free Cash Flow | -2,346 | -5,460 |